• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染 SARS-CoV-2 后儿童对抗原性先进的奥密克戎 BA.5 的中和免疫。

Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection.

机构信息

Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA.

Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

出版信息

J Pediatric Infect Dis Soc. 2024 Jan 29;13(1):100-104. doi: 10.1093/jpids/piad109.

DOI:10.1093/jpids/piad109
PMID:38142128
Abstract

We assessed serum neutralization of Omicron BA.5 in children following SARS-CoV-2 infection during the Delta or Omicron BA.1/BA.2 variant period. Convalescent BA.5 titers were higher following infections during the Omicron BA.1/BA.2 vs Delta variant period, and in vaccinated vs unvaccinated children. Titers against BA.5 did not differ by age group.

摘要

我们评估了在 Delta 或 Omicron BA.1/BA.2 变异株流行期间感染 SARS-CoV-2 的儿童血清对 Omicron BA.5 的中和作用。与 Delta 变异株流行期间相比,Omicron BA.1/BA.2 流行期间感染后 BA.5 的恢复期滴度更高,且在接种疫苗和未接种疫苗的儿童中也是如此。针对 BA.5 的滴度与年龄组无关。

相似文献

1
Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection.感染 SARS-CoV-2 后儿童对抗原性先进的奥密克戎 BA.5 的中和免疫。
J Pediatric Infect Dis Soc. 2024 Jan 29;13(1):100-104. doi: 10.1093/jpids/piad109.
2
Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone.奥密克戎变异株疫苗突破性感染诱导针对 SARS-CoV-2 奥密克戎 BA.1 的交叉中和反应优于单独感染。
Int J Mol Sci. 2022 Jul 12;23(14):7675. doi: 10.3390/ijms23147675.
3
Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections.初次感染 SARS-CoV-2 奥密克戎 BA.1 和 BA.2 株后中和抗体的不同反应特征
Front Immunol. 2022 Jul 19;13:946318. doi: 10.3389/fimmu.2022.946318. eCollection 2022.
4
SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays.康复者接种 SARS-CoV-2 疫苗可增强对奥密克戎亚变体 BA.1、BA.2 和 BA.5 的中和能力,且可通过血清学检测中的抗-S 抗体浓度进行预测。
Front Immunol. 2023 Apr 25;14:1170759. doi: 10.3389/fimmu.2023.1170759. eCollection 2023.
5
Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021.2021 年 1 月至 3 月采集的供体血浆中对 SARS-CoV-2 奥密克戎 BA.1 的中和能力降低。
Microbiol Spectr. 2023 Aug 17;11(4):e0525622. doi: 10.1128/spectrum.05256-22. Epub 2023 Jun 8.
6
Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.COVID-19 患者在突破感染 SARS-CoV-2 变异株 Delta、Omicron-BA.1 和 Omicron-BA.5 期间的免疫反应。
Front Immunol. 2023 Jul 13;14:1150667. doi: 10.3389/fimmu.2023.1150667. eCollection 2023.
7
Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants.奥密克戎亚变体的中和敏感性、融合性和感染性。
Genome Med. 2022 Dec 29;14(1):146. doi: 10.1186/s13073-022-01151-6.
8
Distinct features of SARS-CoV-2 humoral immunity against Omicron breakthrough infection.奥密克戎突破性感染中针对 SARS-CoV-2 体液免疫的独特特征。
Vaccine. 2023 Nov 13;41(47):7019-7025. doi: 10.1016/j.vaccine.2023.10.035. Epub 2023 Oct 17.
9
Humoral Response Kinetics and Cross-Immunity in Hospitalized Patients with SARS-CoV-2 WT, Delta, or Omicron Infections: A Comparison between Vaccinated and Unvaccinated Cohorts.感染新冠病毒野生型、德尔塔或奥密克戎毒株的住院患者的体液免疫反应动力学及交叉免疫:接种疫苗与未接种疫苗队列的比较
Vaccines (Basel). 2023 Dec 1;11(12):1803. doi: 10.3390/vaccines11121803.
10
Neutralizing Antibody Responses against Five SARS-CoV-2 Variants and T Lymphocyte Change after Vaccine Breakthrough Infections from the SARS-CoV-2 Omicron BA.1 Variant in Tianjin, China: A Prospective Study.中国天津地区针对 SARS-CoV-2 奥密克戎 BA.1 变异株疫苗突破性感染后五种 SARS-CoV-2 变异株的中和抗体反应和 T 淋巴细胞变化的前瞻性研究。
Biomed Environ Sci. 2023 Jul 20;36(7):614-624. doi: 10.3967/bes2023.047.

引用本文的文献

1
Overview of COVID-19 Infection, Treatment, and Prevention in Children.儿童新型冠状病毒感染、治疗与预防概述
J Clin Med. 2024 Jan 12;13(2):424. doi: 10.3390/jcm13020424.